Published in Clin Infect Dis on April 14, 2004
Transmission of tropical and geographically restricted infections during solid-organ transplantation. Clin Microbiol Rev (2008) 1.27
NS1 protein secretion during the acute phase of West Nile virus infection. J Virol (2005) 1.22
Detection of seroconversion to West Nile virus, Usutu virus and Sindbis virus in UK sentinel chickens. Virol J (2006) 1.16
Fatal case of deer tick virus encephalitis. N Engl J Med (2009) 1.07
Clinical manifestations and outcomes of West Nile virus infection. Viruses (2014) 1.05
Impact of rituximab-associated B-cell defects on West Nile virus meningoencephalitis in solid organ transplant recipients. Clin Transplant (2009) 1.01
Evaluation of West Nile virus education campaign. Emerg Infect Dis (2005) 0.95
A West Nile virus NS4B-P38G mutant strain induces adaptive immunity via TLR7-MyD88-dependent and independent signaling pathways. Vaccine (2013) 0.87
Role of natural killer and Gamma-delta T cells in West Nile virus infection. Viruses (2013) 0.86
A hamster-derived West Nile virus isolate induces persistent renal infection in mice. PLoS Negl Trop Dis (2013) 0.82
West Nile Virus Infection in the Immunocompromised Patient. Curr Infect Dis Rep (2013) 0.79
A West Nile virus NS4B-P38G mutant strain induces cell intrinsic innate cytokine responses in human monocytic and macrophage cells. Vaccine (2015) 0.78
A hamster-derived West Nile virus strain is highly attenuated and induces a differential proinflammatory cytokine response in two murine cell lines. Virus Res (2012) 0.76
Serological studies of West Nile virus in a liver transplant population. Can J Infect Dis Med Microbiol (2004) 0.75
West Nile Virus Encephalitis in a Patient with Neuroendocrine Carcinoma. Case Rep Oncol Med (2016) 0.75
Confirmation of results of tests for West Nile virus infection in organ transplant recipients. Clin Infect Dis (2004) 0.75
Prospective surveillance for invasive fungal infections in hematopoietic stem cell transplant recipients, 2001-2006: overview of the Transplant-Associated Infection Surveillance Network (TRANSNET) Database. Clin Infect Dis (2010) 5.53
Clinical practice guidelines for the management of patients with histoplasmosis: 2007 update by the Infectious Diseases Society of America. Clin Infect Dis (2007) 5.51
Meta-analysis: the efficacy of strategies to prevent organ disease by cytomegalovirus in solid organ transplant recipients. Ann Intern Med (2005) 4.27
Differentiation and transplantation of human embryonic stem cell-derived hepatocytes. Gastroenterology (2008) 3.99
Effect of eritoran, an antagonist of MD2-TLR4, on mortality in patients with severe sepsis: the ACCESS randomized trial. JAMA (2013) 3.78
Guidelines for evaluation of new fever in critically ill adult patients: 2008 update from the American College of Critical Care Medicine and the Infectious Diseases Society of America. Crit Care Med (2008) 3.67
NCCN clinical practice guidelines in oncology: hepatobiliary cancers. J Natl Compr Canc Netw (2009) 3.25
The neutropenic diet reviewed: moving toward a safe food handling approach. Oncology (Williston Park) (2012) 2.14
Cryptococcus neoformans in organ transplant recipients: impact of calcineurin-inhibitor agents on mortality. J Infect Dis (2007) 1.78
Efficacy of neoadjuvant chemoradiation, followed by liver transplantation, for perihilar cholangiocarcinoma at 12 US centers. Gastroenterology (2012) 1.70
Lipid formulations of amphotericin B significantly improve outcome in solid organ transplant recipients with central nervous system cryptococcosis. Clin Infect Dis (2009) 1.60
Early onset, EBV(-) PTLD in pediatric liver-small bowel transplantation recipients: a spectrum of plasma cell neoplasms with favorable prognosis. Blood (2012) 1.60
Safety, pharmacokinetics, and pharmacodynamics of drotrecogin alfa (activated) in children with severe sepsis. Pediatrics (2004) 1.60
Successful rehabilitation in pediatric ultrashort small bowel syndrome. J Pediatr (2013) 1.45
Interleukin-2 is present in human blood vessels and released in biologically active form by heparanase. Immunol Cell Biol (2011) 1.45
Isolated liver transplantation in infants with end-stage liver disease due to short bowel syndrome. Liver Transpl (2006) 1.41
Higher risk of cytomegalovirus and aspergillus infections in recipients of T cell-depleted unrelated bone marrow: analysis of infectious complications in patients treated with T cell depletion versus immunosuppressive therapy to prevent graft-versus-host disease. Biol Blood Marrow Transplant (2007) 1.39
HCV796: A selective nonstructural protein 5B polymerase inhibitor with potent anti-hepatitis C virus activity in vitro, in mice with chimeric human livers, and in humans infected with hepatitis C virus. Hepatology (2009) 1.38
Regional manifestations and control of the immune system. FASEB J (2002) 1.38
Prevention and treatment of cancer-related infections. J Natl Compr Canc Netw (2008) 1.36
Prevention and treatment of cancer-related infections. J Natl Compr Canc Netw (2012) 1.35
Invasive non-Aspergillus mold infections in transplant recipients, United States, 2001-2006. Emerg Infect Dis (2011) 1.34
Myeloid growth factors. Clinical practice guidelines in oncology. J Natl Compr Canc Netw (2007) 1.23
Lessons learned: critical care management of patients with Ebola in the United States. Crit Care Med (2015) 1.18
Use of interferon-alpha in patients with West Nile encephalitis: report of 2 cases. Clin Infect Dis (2005) 1.17
An immune reconstitution syndrome-like illness associated with Cryptococcus neoformans infection in organ transplant recipients. Clin Infect Dis (2005) 1.14
Anti-HCV therapies in chimeric scid-Alb/uPA mice parallel outcomes in human clinical application. Hepatology (2006) 1.13
Left lobe adult-to-adult living donor liver transplantation: small grafts and hemiportocaval shunts in the prevention of small-for-size syndrome. Liver Transpl (2010) 1.11
Cutaneous cryptococcosis in solid organ transplant recipients. Med Mycol (2010) 1.09
New-onset diabetes after kidney transplantation: an application of 2003 International Guidelines. Transplantation (2005) 1.06
Valganciclovir for cytomegalovirus prevention in solid organ transplant patients: an evidence-based reassessment of safety and efficacy. PLoS One (2009) 1.05
Validation and comparison of clinical prediction rules for invasive candidiasis in intensive care unit patients: a matched case-control study. Crit Care (2011) 1.04
Quantitative versus qualitative cultures of respiratory secretions for clinical outcomes in patients with ventilator-associated pneumonia. Cochrane Database Syst Rev (2008) 1.02
Antifungal management practices and evolution of infection in organ transplant recipients with cryptococcus neoformans infection. Transplantation (2005) 1.02
Use of a panfungal PCR assay for detection of fungal pathogens in a commercial blood culture system. J Clin Microbiol (2004) 1.02
Pharmacoeconomic analysis of microbiologic techniques for differentiating staphylococci directly from blood culture bottles. J Clin Microbiol (2008) 1.00
Efficacy of the oxygen-charged static two-layer method for short-term pancreas preservation and islet isolation from nonhuman primate and human pancreata. Cell Transplant (2002) 0.99
Mucor circinelloides was identified by molecular methods as a cause of primary cutaneous zygomycosis. J Clin Microbiol (2006) 0.98
Antibacterial prophylaxis in patients with neutropenia. J Natl Compr Canc Netw (2007) 0.96
Hepatic fibrosis persists and progresses despite biochemical improvement in children treated with intravenous fish oil emulsion. J Pediatr Gastroenterol Nutr (2013) 0.96
Pulmonary cryptococcosis in solid organ transplant recipients: clinical relevance of serum cryptococcal antigen. Clin Infect Dis (2008) 0.95
Myeloid growth factors. J Natl Compr Canc Netw (2009) 0.94
Unrecognized pretransplant and donor‐derived cryptococcal disease in organ transplant recipients. Clin Infect Dis (2010) 0.94
Calcineurin inhibitor agents interact synergistically with antifungal agents in vitro against Cryptococcus neoformans isolates: correlation with outcome in solid organ transplant recipients with cryptococcosis. Antimicrob Agents Chemother (2007) 0.94
Delayed graft function and cast nephropathy associated with tacrolimus plus rapamycin use. J Am Soc Nephrol (2003) 0.94
Duodenal infusion of feces for recurrent Clostridium difficile. N Engl J Med (2013) 0.93
Mice with chimeric human livers: who says supermodels have to be tall? Hepatology (2005) 0.92
Central nervous system cryptococcosis in solid organ transplant recipients: clinical relevance of abnormal neuroimaging findings. Transplantation (2008) 0.92
Randomized trial of single-dose versus divided-dose rabbit anti-thymocyte globulin induction in renal transplantation: an interim report. Transplantation (2008) 0.92
Methodology for clinical trials involving patients with cancer who have febrile neutropenia: updated guidelines of the Immunocompromised Host Society/Multinational Association for Supportive Care in Cancer, with emphasis on outpatient studies. Clin Infect Dis (2002) 0.92
Is there a role for oral human immunoglobulin in the treatment for norovirus enteritis in immunocompromised patients? Pediatr Transplant (2011) 0.91
Portosystemic shunts in children: a 15-year experience. J Am Coll Surg (2004) 0.90
Sitagliptin therapy in kidney transplant recipients with new-onset diabetes after transplantation. Transplantation (2011) 0.90
Prevention and Treatment of Cancer-Related Infections, Version 2.2016, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw (2016) 0.89
Quantitative versus qualitative cultures of respiratory secretions for clinical outcomes in patients with ventilator-associated pneumonia. Cochrane Database Syst Rev (2012) 0.89
Current management of the short bowel syndrome. Surg Clin North Am (2011) 0.89
Severe sepsis: are PROWESS and PROWESS-SHOCK trials comparable? A clinical and statistical heterogeneity analysis. Crit Care (2013) 0.88
Critical Care for Multiple Organ Failure Secondary to Ebola Virus Disease in the United States. Crit Care Med (2015) 0.88
Cerebral aspergillosis caused by Aspergillus ustus following orthotopic heart transplantation: case report and review of the literature. Clin Transplant (2008) 0.87
Evaluation of the coagulation and inflammatory responses in solid organ transplant recipients and donors. Clin Transplant (2009) 0.87
Molecular identification of Rhizomucor pusillus as a cause of sinus-orbital zygomycosis in a patient with acute myelogenous leukemia. J Clin Microbiol (2005) 0.87
Current management of short bowel syndrome. Curr Probl Surg (2012) 0.87
Perlecan: a major IL-2-binding proteoglycan in murine spleen. Immunol Cell Biol (2007) 0.86
No place like home? Outpatient management of patients with febrile neutropenia and low risk. J Clin Oncol (2011) 0.85
Treatment and outcomes of invasive fusariosis: review of 65 cases from the PATH Alliance(®) registry. Mycoses (2014) 0.85
Greater early pancreas graft loss in women compared with men after simultaneous pancreas-kidney transplantation. Clin Transplant (2005) 0.84
Quantitative versus qualitative cultures of respiratory secretions for clinical outcomes in patients with ventilator-associated pneumonia. Cochrane Database Syst Rev (2014) 0.84
The "last breath" of the ventilator-associated pneumonia surveillance definition*. Crit Care Med (2014) 0.84
Presumptive serum sickness as a complication of rabbit-derived antithymocyte globulin immunosuppression. Arthritis Rheum (2009) 0.84
Stool calprotectin monitoring after small intestine transplantation. Transplantation (2011) 0.83
Linezolid does not show advantages over vancomycin in modulating the pulmonary immune response: how should we conciliate these new findings with the Zephyr trial results? Crit Care Med (2011) 0.83
A randomized 2×2 factorial trial, part 1: single-dose rabbit antithymocyte globulin induction may improve renal transplantation outcomes. Transplantation (2015) 0.83
Unresolved questions with the use of linezolid vs vancomycin for nosocomial pneumonia. Chest (2004) 0.83
Mild donor liver steatosis has no impact on hepatitis C virus fibrosis progression following liver transplantation. Liver Int (2007) 0.83
An international survey of cytomegalovirus prevention and treatment practices in intestinal transplantation. Transplantation (2014) 0.83
Antithymocyte globulin induction in living donor renal transplant recipients: final report of the TAILOR registry. Transplantation (2012) 0.83
Strategies to optimize donor safety with smaller grafts for adult-to-adult living donor liver transplantation. Curr Opin Organ Transplant (2012) 0.82
An epidemiological analysis of acute flaccid paralysis and its surveillance system in Iraq, 1997-2011. BMC Infect Dis (2014) 0.82
Massive small bowel resection during pregnancy causing short bowel syndrome. Am Surg (2011) 0.82
Intestinal transplantation in children with multiple intestinal atresias and immunodeficiency. Pediatr Transplant (2013) 0.82
Cytomegalovirus infections in non-immunocompromised and immunocompromised patients in the intensive care unit. Infect Disord Drug Targets (2011) 0.82
A model of tuberculosis transmission and intervention strategies in an urban residential area. Comput Biol Chem (2010) 0.81
Risk of cytomegalovirus disease in high-risk liver transplant recipients on valganciclovir prophylaxis: a systematic review and meta-analysis. Liver Transpl (2012) 0.81
Intravenous ascorbic acid to prevent and treat cancer-associated sepsis? J Transl Med (2011) 0.81